Taysha Gene Therapies, Inc. (TSHA)
5.50
-0.16
(-2.83%)
USD |
NASDAQ |
Dec 31, 16:00
5.50
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Price: 5.50 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AngioDynamics, Inc. | 12.84 |
| Anavex Life Sciences Corp. | 3.56 |
| Bolt Biotherapeutics, Inc. | 5.468 |
| Neurogene, Inc. | 20.60 |
| Aspire Biopharma Holdings, Inc. | 0.1319 |
Price Related Metrics
| PS Ratio | 245.27 |
| PEG Ratio | -0.0164 |
| Price to Book Value | 6.880 |
| Earnings Yield | -6.44% |
| Market Cap | 1.507B |
| PEGY Ratio | -0.0164 |